Obesity drug linked to mental disorders

AN anti-obesity drug has been withdrawn from sale in Ireland over links to mental disorders.

The Irish Medicines Board (IMB) confirmed last night that the prescription-only drug, Acomplia, would no longer be available on the Irish market.

The IMB’s decision is in line with the European Medicines Agency (EMEA) recommendation that the licence for the drug, marketed by Sanofi-Aventis, be suspended across the EU.